An Update on Intracerebral Hemorrhage
An Update on Intracerebral Hemorrhage - A Cohort Study
The intracerebral hemorrhage study is a multicenter , combination of prospective and retrospective observational cohort study led by Dr. Muhammad Junaid Akram, PhD scholar at Chongqing Medical University. Prof Dr. Qi Li will be the senior consultant for the study. The study will be focusing on natural history, epidemiological , radiological, rehabilitative and clinical aspects as well as the effect of various treatments on the hemorrhagic patients.
The study related data of the patients diagnosed with intracerebral hemorrhage will be collected in prospective and retrospective ways. The prognostic data for the patients will be assembled and collected via using different outcome measures at different points of time.
研究概览
详细说明
研究类型
注册 (预期的)
联系人和位置
学习联系方式
- 姓名:Muhammad Junaid Akram, DPT, MS-NMPT
- 电话号码:0092-335-1402214
- 邮箱:drjunaidmalik2@gmail.com
研究联系人备份
- 姓名:Muhammad Junaid Akram
- 电话号码:0092-335-1402214
- 邮箱:drjunaidmalik2@gmail.com
学习地点
-
-
-
Islamabad、巴基斯坦、46000
- 招聘中
- Shifa tameer e millat university
-
接触:
- Muhammad Junaid Akram, PhD*
- 邮箱:drjunaidmalik2@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Age > 18 years Patients willing to participate via signing a consent form' Patients diagnosed with CT-Confirmed spontaneous intracerebral hemorrhage (ICH) Patients willing to participate in the follow up assessment
Exclusion Criteria:
- Not willing to participate Secondary ICH to hemorrhagic infarction or tumor bleeding etc. Traumatic ICH
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
---|
Benign Hematoma
Patients (having novel image markers or clinical features) suggestive of a benign hematoma relatively , that is having relatively good prognostic outcome and less likely to expand.
|
Malignant Hematoma
Patients (having novel image markers or clinical features) suggestive of a malignant hematoma relatively, that is more likely to expand and have poor prognostic outcome.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
24小时血肿体积增长
大体时间:24小时
|
评估 24 小时的早期血肿体积增长
|
24小时
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Functional outcome at 3 months assessed by modified Rankin Scale
大体时间:3 months
|
Assess functional outcome at 3 months by using mRS
|
3 months
|
Early neurological deterioration assessed by NIHSS score at 24 hours
大体时间:24 hours
|
To assess early neurological deterioration by using NIHSS score at 24 hours
|
24 hours
|
Early neurological deterioration assessed by NIHSS score at 48 hours
大体时间:48 hours
|
To assess early neurological deterioration by using NIHSS score at 48 hours
|
48 hours
|
Early neurological deterioration assessed by NIHSS score at 72 hours
大体时间:72 hours
|
To assess early neurological deterioration by using NIHSS score at 72 hours
|
72 hours
|
Perihematomal edema volume measurement at 24 hours
大体时间:24 hours
|
To measure the perihematomal edema volume growth at 24 hours
|
24 hours
|
Perihematomal edema volume measurement at 48 hours
大体时间:48 hours
|
To measure the perihematomal edema volume growth at 48 hours
|
48 hours
|
Perihematomal edema volume measurement at 72 hours
大体时间:72 hours
|
To measure the perihematomal edema volume growth at 72 hours
|
72 hours
|
Intraventricular hemorrhage growth
大体时间:24 hours
|
To assess the presence of IVH at 24 hours
|
24 hours
|
Major thrombotic events
大体时间:2 weeks
|
To assess the thrombotic events 2 weeks after admission
|
2 weeks
|
合作者和调查者
调查人员
- 首席研究员:Muhammad Junaid Akram, DPT, MS-NMPT、Chongqing Medical University, Chongqing / Shifa Tameer e Millat University, Islamabad
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.